A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)

Clinical trial NCT00750334 · TERMINATED

Trial details

NCT number: NCT00750334
Sponsor: Genzyme, a Sanofi Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2008-09-01
Primary completion: 2008-10-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.